AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 20th, 2017 • PTC Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Amendment No. 1, dated as of April 20, 2017 (this “Amendment”), to the Asset Purchase Agreement (the “Agreement”), dated as of March 15, 2017, is made and entered into by and between PTC Therapeutics, Inc., a Delaware corporation (“Buyer”), and Marathon Pharmaceuticals, LLC, a Delaware limited liability company (“Seller”). Capitalized terms used, but not otherwise defined, in this Amendment shall have the meanings ascribed to them in the Agreement. Buyer and Seller may be referred to herein, together, as the “Parties” and, individually, as a “Party”.
